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South Africa, home to the world’s largest population of people living 
with HIV (5.7 million), experienced a measles outbreak that started 
in late 2009.1 There was a stepped increase in cases of measles, 
with the highest incidence reported in March 2010.2 By September 
2010, more than 17 000 new measles cases had been reported to the 
National Institute of Communicable Diseases since January 2009. 
A mass vaccination campaign from mid-April to early May 2010 
resulted in a significant decline in new measles cases.
The measles virus is highly contagious, and outbreaks are fuelled by 
overcrowding and poor vaccine coverage, making elimination status 
in South Africa difficult to attain. Measles may infect the central 
nervous system (CNS) as acute viral encephalitis, or result after 2 - 4 
weeks in a post-infectious immune-mediated inflammatory disorder 
or acute disseminated encephalomyelitis (ADEM). There are 2 
further rare and latent CNS complications resulting from a preceding 
measles infection: subacute sclerosing panencephalitis (SSPE) caused 
by years of viral persistence in a seemingly immunocompetent 
host,3 and subacute measles encephalitis (SME), occurring in an 
immunocompromised host.4
SME manifests 1 - 7 months after the acute measles infection.5 
Patients present with seizures, often epilepsy partialis continua, and 
altered mental status.5 It carries a mortality rate of 85% and survivors 
often have significant psychomotor retardation.5  SME has hitherto only 
been described in single case reports as a rare complication of measles in 
the context of organ transplantation,6,7 immunosuppressive therapy or 
immunodeficiencies,5,8 and HIV and AIDS.5,9,10 We report 8 cases of SME 
in HIV-infected patients who presented to a tertiary referral hospital 
between July and October 2010.
Case reports
The index case (Patient 1), known to be HIV-positive, presented with a 
2-week history of focal twitching and clumsiness of the right hand and 
secondary generalised seizures on 3 occasions. Three months earlier, 
she contracted measles complicated by pneumonitis (Table I). She was 
unable to recall ever receiving measles vaccination. She recovered and 
commenced antiretroviral treatment (ART) 4 weeks later as well as 
co-trimoxazole prophylaxis. Her nadir CD4 cell count was 67 cells/µl. 
She had never travelled and did not abuse illicit substances.
Other than the epilepsy partialis continua (focal motor status 
epilepticus) of the right hand with dystonic posturing of the left foot 
and intermittent leg twitching, she was initially relatively well. She 
reported no headache, and on examination was afebrile, co-operative 
and not encephalopathic. Serum biochemistry including glucose was 
normal. She had evidence of immune reconstitution with a CD4 count 
of 286 and an undetectable serum HIV viral load. Cerebrospinal fluid 
(CSF) was acellular with normal biochemistry and negative tests for 
neurosyphylis and cryptococcal antigen. CSF cultures for bacteria, 
fungi and tuberculosis were negative. CSF polymerase chain reaction 
(PCR) tests were repeatedly negative for herpes simplex virus 1 and 
2, cytomegalovirus, JC virus, Epstein Barr virus, herpesvirus 6, fungi, 
toxoplasmosis, enteroviruses and measles. The HIV viral load in the 
CSF was undetectable. The electroencephalogram (EEG) showed left 
periodic lateralised epileptiform discharges (PLEDs). Brain imaging 
showed no abnormalities, but there was subtle non-enhancing left 
frontal cortical hyperintensity on the TR sequences of the initial MRI 
(week 3 of SME).
The patient deteriorated rapidly over the following weeks from 
being independent to requiring assistance with walking and feeding. 
Her vision deteriorated and she developed dilated, sluggishly reactive 
pupils. There was no evidence of corneal or retinal involvement 
and no papiloedema. A repeat brain MRI showed contiguous 
spread of the left frontal lesion (Fig. 1) and additional multifocal 
T2-hyperintensities, but again limited to the cortical ribbon. A 
brain biopsy revealed non-necrotising encephalitis with eosinophilic 
inclusions, suggestive of viral aetiology. Measles PCR on brain tissue 
was positive, confirming SME. The seizures were finally controlled 
with a combination of valproate, levitiracetam and clonazepam. 
Despite commencement on oral ribavirin, her level of consciousness 
deteriorated. She is currently mute and unresponsive.
We identified a further 7 patients with either definite or probable 
SME. We classified as ‘definite SME’ a suggestive clinical picture 
(focal seizures and/or encephalopathy) and a positive measles PCR 
in either brain biopsy, CSF or urine. ‘Probable SME’ was diagnosed 
in the context of a suggestive clinical picture, normal CSF findings 
in the absence of other identifiable pathogens, and with supportive 
features such as MRI demonstrating multifocal grey matter signal 
abnormalities and/or positive CSF measles serology (IgG).
Table I shows the clinical characteristics of the 8 patients with 
definite and probable SME (N=3). The median age was 28 years 
(range 14 - 38); all were HIV-positive (newly diagnosed in 3); one was 
known to be on ART at the time of measles infection. The median 
CD4+ count at presentation was 37 (range 1 - 268); 4 had a history of 
a morbiliform rash, and the median time to presentation with SME 
following rash was 12.5 weeks. All patients developed seizures, but 
3 presented with focal motor status or epilepsia partialis continua. 
Blindness and deafness constituted the other modes of presentation. 
Patient 2 developed hearing loss a few weeks after being immunised 
against measles as part of the nationwide measles campaign (his 
HIV status unknown at the time). Subsequent genotyping of the 
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measles virus detected in his CSF revealed wild-type measles and 
not the vaccine strain. SME was fatal in 6 patients, and the mean 
time between onset of SME and death was 21 days. The clinical 
and radiological picture of patient 8, who may have been on ART 
at the time of measles infection, appears to have stabilised prior 
to the initiation of ribavirin between 9 and 10 weeks. He presently 
has normal higher mental functions and seizures are controlled on 
valproate.
The laboratory and radiological investigations are shown in 
Table II. Routine CSF examinations were non-contributory. The 
MRI appearance was remarkably similar in the 7 patients scanned: 
T2-signal abnormality in a distinctive patchy cortical distribution, 
but in some also involving the deep basal ganglia consistent with a 
polioencephalopathy. White-matter abnormalities were variable and 
infrequent.
Discussion
This is the largest SME case series to date – and, alarmingly, 
collected over 4 months. All patients were HIV-positive and, with 
one exception, had CD4 counts <100 cells/µl at the time of measles 
infection, consistent with SME as an opportunistic infection in an 
immunocompromised host.4 The measles virus enters the CNS 
with the initial viraemia, but it is thought that a poor cell-mediated 
immune response allows virus to persist in this compartment with the 
potential for SME.4 Interestingly, the 2 survivors were those with the 
least compromised CD4 counts; one had reconstituted on ART and the 
other was the least affected clinically. In immunosuppressed animals 
infected with the measles virus, the repopulation of lymphocytes 
was associated with the elimination of viraemia,4 suggesting that 
immune reconstitution in HIV-infected patients may enable a more 
robust immune response. Furthermore, human leukocyte antigen 
(HLA) polymorphisms influence measles antibody responses, which 
may be a modifying factor influencing susceptibility to this measles 
complication.11
Focal seizures are well described in SME although the mechanism 
by which the measles virus induces epileptogenicity is not clear. 
When neurotropic measles virus is inoculated into mouse brain, 
Table I. Characteristics of subjects at presentation of subacute measles encephalitis (SME)
Pt 1 Pt 2 Pt 3* Pt 4 Pt 5* Pt 6 Pt 7* Pt 8
Age (years) 27 14 29 25 32 34 24 38
Gender F M F M F F F M














































































































*Refers to probable cases, the remainder are definite cases (see text).
†If known.
‡Patient on ART for 1 year preceding presentation.
M = male; F = female; Y = yes; N = no; ART = antiretroviral therapy; UK = unknown; EPC = epilepsy partialis continua; NA = not applicable.
Fig. 1. Patient 1: Sequential axial brain MRI T2 FLAIR images 2 weeks apart 
showing contiguous extension of the left frontal hyperintense lesion.
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neuroglial excitotoxicity (probably via N-methyl D-aspartate 
(NMDA)-receptor signaling) preceded neuronal hyperexcitability 
resulting in intermittent and later continuous seizures, followed by 
neuronal cell loss.12
Acute onset visual loss and deafness have been infrequently reported 
in SME; however, sensorineural hearing loss,13 keratitis and corneal 
scarring resulting in blindness, particularly in the presence of vitamin 
A deficiency, are known complications of acute measles.13 Preferential 
involvement of occipital, thalamic and putaminal areas occur in 
SSPE.14 In our patients with visual impairment, there was clinical 
evidence of anterior visual pathway involvement (abnormal pupillary 
responses) and, on MRI, posterior (occipital and/or temporal lobe) 
visual pathway involvement (Fig. 2). The recognition of visual and 
hearing loss may be important in considering a diagnosis of SME.
SME is an elusive diagnosis. The preceding measles rash may 
be subtle or absent in an immunocompromised host.4 The CSF 
examination may be normal, and specific measles testing using 
antibodies and more sensitive PCR may be negative. Absence of 
measles virus DNA in the CSF is probably due to the intraneuronal 
location of the measles virus and, unlike non-neuronal cells, viral 
budding and shedding does not occur in the CNS.15 Further, in the 
CNS, measles viral transmission occurs via trans-synaptic neuronal 
spread,15 which may explain the contiguous cortical spread on 
sequential MRI brain images (Figs 1a, b). Therefore, in the absence 
of finding evidence of ongoing measles virus infection in the CSF, a 
definitive diagnosis would require brain biopsy.
Two outbreaks of measles have occurred in South Africa in 
the last decade, with one still ongoing.16 Failure to vaccinate a 
critical percentage of the population is the probable cause. Vaccine 
effectiveness may be lowered in HIV infection, but the population 
vaccine effectiveness remained high,16 underscoring the importance 
of immunisation programmes in an HIV-endemic population.
The fatal intersection of HIV and measles has resulted in a cluster 
of patients in South Africa with subacute measles encephalitis, 

Fig. 2. Axial T2 FLAIR images demonstrating: A (Patient 6) – bilateral temporal-parietal 
cortical hyperintensities; B (Patient 2) – parieto-occipital cortical hyperintensities; C (Patient 3) 
– superficial cortical (left frontal and bilateral occipital) and deep grey matter (bilateral head of 
caudate) hyperintense signal abnormalities; and D (Patient 8) – hyperintense signal changes in 
the right occipital cortex. 

Fig. 2. Axial T2 FLAIR images demonstrating: A (Patient 6) – bilateral 
temporal-parietal cortical hyperintensities; B (Patient 2) – parieto-occipital 
cortical hyperintensities; C (Patient 3) – superficial cortical (left frontal and 
bilateral occipital) and deep grey matter (bilateral head of caudate) hyperin-
tense signal abnormalities; and D (Patient 8) – hyperintense signal changes 
in the right occipital cort .
Table II. Laboratory, pathology and radiological investigations in subjects
Pt 1 Pt 2 Pt 3 Pt 4 Pt 5 Pt 6 Pt 7 Pt 8
















































EEG PLEDS PLEDS PLEDS Slowing Slowing PLEDS Slowing Normal
CT brain Normal Normal Normal Normal Normal Normal Normal Abnormal
Location of MRI signal 
abnormalities
    Superficial grey matter
    Deep grey matter






















Histopathology INI ND INI ND ND INI INI ND
*Post-mortem brain biopsy.
†PCR failed on formalin fixed tissue.
Pos = positive; Neg = negative; ND = not done; PLEDS = periodic lateralised epileptiform discharges;  
INI = intranuclear and cytoplasmic inclusion bodies.
FORUM
317
many of whom might have died before reaching medical attention, 
which serves to remind clinicians of the importance of a vigilant 
and effective measles immunisation programme. By reporting these 
patients who present with focal seizures, often with hearing and 
visual loss and with evidence of a polioencephalopathy on MRI, we 
aim to raise awareness of this devastating complication. Although 
insensitive, we propose the use of measles virus PCR in CSF and/or 
urine as a time- and cost-effective way of confirming the diagnosis of 
SME in the absence of a brain biospy.
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